It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The impact of most, but not all, cardiovascular risk factors decline by age. We investigated how the metabolic syndrome (MetS) was related to cardiovascular disease (CVD) during 40 years follow-up in the Uppsala Longitudinal Study of Adult Men (ULSAM, 2,123 men all aged 50 at baseline with reinvestigations at age 60, 70, 77 and 82). The strength of MetS as a risk factor of incident combined end-point of three outcomes (CVD) declined with ageing, as well as for myocardial infarction, ischemic stroke and heart failure when analysed separately. For CVD, the risk ratio declined from 2.77 (95% CI 1.90–4.05) at age 50 to 1.30 (95% CI 1.05–1.60) at age 82. In conclusion, the strength of MetS as a risk factor of incident CVD declined with age. Since MetS was significantly related to incident CVD also at old age, our findings suggest that the occurrence of MetS in the elderly should not be regarded as innocent. However, since our data were derived in an observational study, any impact of MetS in the elderly needs to be verified in a randomized clinical intervention trial.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Uppsala University, Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden (GRID:grid.8993.b) (ISNI:0000 0004 1936 9457)
2 Uppsala University, Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden (GRID:grid.8993.b) (ISNI:0000 0004 1936 9457); University of New South Wales, The George Institute for Global Health, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
3 Karolinska Institutet, Division of Family Medicine and Primary Care, Department of Neurobiology, Care Sciences and Society, Huddinge, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Dalarna University, School of Health and Social Sciences, Falun, Sweden (GRID:grid.411953.b) (ISNI:0000 0001 0304 6002)
4 Uppsala University, Department of Public Health and Caring Sciences, Uppsala, Sweden (GRID:grid.8993.b) (ISNI:0000 0004 1936 9457)
5 Uppsala University, Uppsala Clinical Research Center, Uppsala, Sweden (GRID:grid.8993.b) (ISNI:0000 0004 1936 9457)